Streetbeat News

Earnings

SNAP

Analysts have mixed views on Snap Inc. (NYSE:SNAP), with ratings ranging from bullish to bearish. Over the last quarter, there have been shifts in sentiment, with the most recent month showing a more cautious stance. The average 12-month price target is $13.9, up 57.42% from the previous $8.83, with a high estimate of $23.00 and a low of $7.00. Several analysts have raised their price targets, while others maintain or have a neutral stance. Snap's financials show a lower market cap compared to industry averages, a revenue growth of 5.32%, but struggles with profitability and debt management.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 12:01 pm

ANF

Abercrombie & Fitch (NYSE:ANF) has been analyzed by 8 analysts, showing a shift towards a more bullish sentiment with 4 somewhat bullish and 4 indifferent ratings. The average 12-month price target for ANF is now $78.88, up 14.55% from the previous target of $68.86. Analysts from Telsey Advisory Group, Citigroup, UBS, and Morgan Stanley have raised their price targets, reflecting positive expectations for the company's performance. Abercrombie & Fitch has demonstrated strong financial health with a 20.04% revenue growth rate, a net margin of 9.11%, an ROE of 11.77%, an ROA of 3.38%, and a conservative debt-to-equity ratio of 1.27.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 12:01 pm

CRWD

CrowdStrike Holdings (NASDAQ:CRWD) has been the subject of 37 analyst ratings over the past three months, with a trend towards bullish sentiment. The average 12-month price target is $239.57, with a high of $325.00 and a low of $180.00, indicating a 13.43% increase from the previous average of $211.21. Analysts from firms such as Morgan Stanley, Oppenheimer, and Goldman Sachs have raised their price targets, reflecting positive market dynamics and company performance. CrowdStrike's financial health is strong, with a revenue growth rate of 35.31%, a net margin of 3.39%, and an ROA of 0.47%, although its ROE of 1.38% is below industry benchmarks. The company's debt-to-equity ratio is conservative at 0.39.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 12:00 pm

EXTR

Extreme Networks Inc (NASDAQ:EXTR) shares dropped over 6% after the company reduced its Q2 revenue guidance. The new forecast is between $294 million to $297 million, down from the previous range of $312 million to $327 million, and below the consensus estimate of $320.51 million. Despite a projected 41% Y/Y increase in subscription and support revenue, and an expectation for recurring revenue to make up 33% of total revenue, the company cited industry headwinds and longer sales cycles for the revision. The Q2 gross margin is expected to be at the higher end of the 59.5%-61.5% range. EXTR also repurchased $25 million in shares and reported a cash balance of $221.4 million. The Q2 earnings results will be announced on January 31, 2024.

Portfolio Pulse from Lekha Gupta

January 09, 2024 | 11:56 am

EXK

Endeavour Silver Corp. reported its full year 2023 production, totaling 5.7 million ounces of silver and 37,858 ounces of gold, which equates to 8.7 million silver equivalent ounces. The fourth quarter contributed 1.4 million ounces of silver and 9,440 ounces of gold to this total.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:55 am

CAH

Cardinal Health has updated its FY24 adjusted EPS guidance to the higher end of the $6.75-$7.00 range, exceeding the $6.95 estimate. The company also plans to execute a new $250M accelerated share repurchase program in Q2. Cardinal Health reiterated its long-term targets, aiming for a 12%-14% growth in adjusted EPS. The update is attributed to strong cash flow generation leading to higher cash balances and favorable fiscal conditions.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:52 am

BNTX

BioNTech presented its strategic priorities for 2024 at the J.P. Morgan Healthcare Conference, aiming to have ten or more registrational trials by the end of 2024 and to be commercial-ready by the end of 2025. The company reported an unaudited €17.5 billion in cash and equivalents for 2023 and anticipates revenues of about €3 billion for 2024.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:46 am

ES

Eversource Energy (NYSE:ES) is in advanced talks to sell its 50% stake in three offshore wind projects to a global private infrastructure investor. The company will record an impairment charge of $1.4-$1.6 billion in Q4 due to revised construction costs, which will not affect future cash flows or current cash balances. Eversource will provide 2024 earnings guidance and other financial forecasts in an upcoming earnings call.

Portfolio Pulse from Shivani Kumaresan

January 09, 2024 | 11:44 am

NARI

Inari Medical announced preliminary unaudited revenue for Q4 2023 of at least $132M, a 22% increase year-over-year, surpassing the consensus estimate of $130.98M. The company also reported preliminary unaudited revenue for FY23 of at least $493.5M, a 29% increase year-over-year, slightly above the consensus estimate of $492.61M.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:35 am

MSM

MSC Industrial Direct Co (NYSE:MSM) reported Q1 adjusted EPS of $1.25, missing the $1.31 estimate, and sales of $954M, below the $972.06M estimate. This reflects a 15.54% decrease in EPS and a 0.39% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:31 am